SynthesisFrontiers in medicine2026
The prognostic value of the CALLY index in sepsis: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CALLY Index and Inflammatory Parameters for Predicting Focal Involvement in Human Brucellosis: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Immune-inflammatory-nutritional dysfunction in HIV-negative patients with asymptomatic neurosyphilis: a retrospective comparative study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The C-reactive protein-albumin-lymphocyte (CALLY) index is a composite biomarker of inflammation, nutrition, and immunity, yet its prognostic value in sepsis remains uncertain due to inconsistent evidence. This meta-analysis seeks to clarify the relationship between the CALLY index and prognosis in septic patients. Methods: A systematic search of PubMed, Embase, OVID, Web of Science, the China National Knowledge Infrastructure, the Wanfang Database, Google Scholar, and Baidu Scholar was conducted up to November 15, 2025. Studies reporting on the CALLY index's association with mortality or its levels in sepsis survivors versus non-survivors were included. Data were pooled using standardized mean differences (SMDs), hazard ratios (HRs), and odds ratios (ORs) with 95% confidence intervals (CIs) under a random-effects model. Results: This meta-analysis incorporated a total of six studies, encompassing seven cohorts and comprising 3,848 patients with sepsis. Overall, the CALLY index did not significantly differ between survivors and non-survivors (pooled SMD = -0.22, 95% CI: -1.18 to 0.74). However, subgroup analyses revealed a marked divergence: a higher CALLY index was correlated with survival in Chinese cohorts (SMD = -1.04, 95% CI: -1.69 to -0.39), whereas it was associated with mortality in the Turkish cohort (SMD = 1.39, 95% CI: 1.02 to 1.75). Multivariate analysis further showed a significant association between a higher CALLY index and a lower mortality risk (HR = 0.48, 95% CI: 0.33-0.69). The diagnostic accuracy of the CALLY index for predicting mortality was moderate, with a pooled sensitivity of 0.59 and specificity of 0.77. Significant heterogeneity was observed across all pooled analyses. Conclusion: The CALLY index shows promise as a low-cost sepsis biomarker, but its variable link to mortality across ethnic groups requires validation in large, multinational prospective studies. Systematic review registration: Identifier: INPLASY2025120023. http://inplasy.com.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.